The latest biotech news

News and Trends 7 Apr 2015

Open Bionics, lending a 3D-Printed helping hand

Little could the young Joel Gibbard have ever imagined that those Meccano games he once used to play with as a child, would one day lead him to become Britain’s Design Engineer of the Year amongst other prestigious awards. Open Bionics, the Bristol-based company he founded, aims at providing low-cost robotic hands. I got to […]

April 7, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 6 Apr 2015

Gene editing to make French fries less unhealthy

A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an average of €126M on the development of a genetically engineered crop (GMO), including €32M in regulatory costs. The Agriculture Department once takes two to five years to review applications, though it is trying to reduce that to 13 to 16 […]

April 6, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 4 Apr 2015

An Exclusive Agreement Supporting Patients Requiring Access to an Intravenous Nutritional Therapy

April 4, 2015 - 0 minutesmins - By Julie Lellouche

News and Trends 3 Apr 2015

Back to Middle Age to re-discover some medicinal treatments

The long medieval period extends in the West over nearly a millennium and gradually enriched its knowledge in the medical field. Admired by the Greeks, Egyptian medicine made reference in Western medicine for millennia. Medical papyri mention over seven hundred healing substances, plant, animal, mineral, composing over a thousand remedies often associated with incantations to […]

April 3, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 3 Apr 2015

The Strategic Focus of Roche-Genentech on Personal Genetic data

Personal Genetic data plays more and more a critical role in drug development. Major Pharma company Roche and its Biotech subsidiary Genentech are iconic in this trend. They have always been the first ones to catch up the wave and get profit from it. Today, Genentech believes and focus on genome sequencing to continue bringing breakthrough […]

April 3, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 2 Apr 2015

Anergis completed Phase II for AllerT, a novel treatment for pollen allergies

Anergis announced treatment completion of its Phase II clinical trial of AllerT, a novel long-peptide immunotherapeutic to treat birch pollen allergies. Anergis’ approach uses synthetic, pharmaceutical-grade Contiguous Overlapping Peptide (“COP”), peptides of 40-80 amino-acids which are safer (no risk of immediate allergic reaction) and can elicit a faster immune response than the allergenic proteins they […]

April 2, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 2 Apr 2015

Interview with CELLPROTHERA, the regenerative medicine pioneer

CellProthera is a medical biotech company founded in 2008 in Mulhouse, France. The young innovative company focuses on the use of blood peripheral stem cells. CellProthera is the origin of a revolutionary therapy allowing the regeneration of myocardial tissue following acute myocardial infarct (AMI) by injection of a cell graft containing autologous adult stem cells […]

April 2, 2015 - 7 minutesmins - By Nicolas Sainte-Foie

News and Trends 1 Apr 2015

Cardio3 will launch an IPO in the United States

Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced its intention to conduct a registered public offering in the United States. The timing, number of shares and price of the proposed offering have not yet been determined. A draft registration statement relating to […]

April 1, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 31 Mar 2015

Merck Serono and Intrexon, to develop CAR-T Therapy

Merck Sereno, the biopharmaceutical business of Merck, and the synthetic biology leader Intrexon announced yesterday an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. CAR-T cells are genetically engineered T-cells with synthetic receptors that recognize a specific antigen expressed on tumor cells. When CAR-T cells bind to a target, […]

March 31, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 30 Mar 2015

#BioFigures: €406 Million Antibody-drug conjugate Deal struck by ImmunoGen andTakeda

WHO? ImmunoGen is a biotechnology company that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate (ADC) technology. The Company’s uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells. The first product with ImmunoGen’s ADC technology is Roche‘s Kadcyla. ImmunoGen has three wholly owned product candidates in clinical testing with additional compounds […]

March 30, 2015 - 3 minutesmins - By Marie Godar

News and Trends 28 Mar 2015

Strategic Partnership Between Green Cross and Nanolek

The South Korean biopharmaceutical company Green Cross and the Russian pharmaceutical company Nanolek signed a strategic partnership agreement for the commercialisation of Green Cross’ biologics in the Russian market. Green Cross provides healthcare solutions that address the evolving needs of human health. The company is specialised in the development and manufacturing of plasma-derivatives, vaccines and recombinant […]

March 28, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 27 Mar 2015

OSE Pharma raised €21.1 Million

OSE Pharma’s Initial Public Offering couldn’t have been more successful as it just raised €21.1M. Noticing the strong demand for shares, the board of OSE Pharma has increased the price of the capital to €10.80 per share, corresponding to the top of the indicative price range of the offer. On this basis, the market capitalization […]

March 27, 2015 - 1 minutemin - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Open Bionics, lending a 3D-Printed helping hand

Gene editing to make French fries less unhealthy

An Exclusive Agreement Supporting Patients Requiring Access to an Intravenous Nutritional Therapy

Back to Middle Age to re-discover some medicinal treatments

The Strategic Focus of Roche-Genentech on Personal Genetic data

Anergis completed Phase II for AllerT, a novel treatment for pollen allergies

Interview with CELLPROTHERA, the regenerative medicine pioneer

Cardio3 will launch an IPO in the United States

Merck Serono and Intrexon, to develop CAR-T Therapy

#BioFigures: €406 Million Antibody-drug conjugate Deal struck by ImmunoGen andTakeda

Strategic Partnership Between Green Cross and Nanolek

OSE Pharma raised €21.1 Million

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!